This issue is available in PDF format to paid subscribers (certain restrictions apply).
If you have not already registered for Full Text Access to The Journal, then visit our registration page.

VOLUME 60   1999   NUMBER 10


647 Molecular Neurobiology for Practicing Psychiatrists, Part 2: How Neurotransmitters Activate Second Messenger Systems. Stephen M. Stahl


649 The Texas Medication Algorithm Project (TMAP) Schizophrenia Algorithms. Alexander L. Miller, John A. Chiles, Judith K. Chiles, M. Lynn Crismon, A. John Rush, and Steven P. Shon

658 A Comparative Effectiveness Study of Risperidone and Olanzapine in the Treatment of Schizophrenia. Beng-Choon Ho, Del Miller, Peg Nopoulos, and Nancy C. Andreasen

664 Droperidol: Efficacy and Side Effects in Psychiatric Emergencies. R. Andrew Chambers and Benjamin G. Druss

668 Zolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients. Gregory M. Asnis, Amal Chakraburtty, Eugene A. DuBoff, Andrew Krystal, Peter D. Londborg, Russell Rosenberg, Barbara Roth-Schechter, Martin B. Scharf, and James K. Walsh

677 The Reliability and Validity of a Screening Questionnaire for 13 DSM-IV Axis I Disorders (the Psychiatric Diagnostic Screening Questionnaire) in Psychiatric Outpatients. Mark Zimmerman and Jill I. Mattia

684 Withdrawal From Controlled Carbamazepine Therapy Followed by Further Carbamazepine Treatment in Patients With Dementia. Pierre N. Tariot, Laura J. Jakimovich, Rosemary Erb, Christopher Cox, Benjamin Lanning, Carrie Irvine, and Carol Ann Podgorski

690 The Effectiveness of Antidepressants in Elderly Depressed Outpatients: A Prospective Case Series Study. Nicole Mittmann, Nathan Herrmann, Kenneth I. Shulman, Ivan L. Silver, Usoa E. Busto, E. Keith Borden, Claudio A. Naranjo, and Neil H. Shear

698 Donepezil for Psychotropic-Induced Memory Loss. Frederick M. Jacobsen and Lillian Comas-Diaz

CME Activity 713

714 Critical Overview: Adverse Cutaneous Reactions to Psychotropic Medications. Arash Kimyai-Asadi, James C. Harris, and Hossein C. Nousari


705 Upper-Extremity Self-Amputation in a Case of Dissociative Identity Disorder. Ira Brenner

Reply by Steven C. Schlozman

706 Anetholtrithion Stabilizes Body Weight Fluctuation Caused by Excessive Water Drinking in a Patient With Schizophrenia: A Case Report. Sin-ichiro Matsuo, Hideaki Ninomiya, Tetsujiro Takasiba, and Yunosin Sasaki

706 Relative Weight Gain Among Antipsychotics. Prakash S. Masand

Reply by Steven M. Stahl

708 Venlafaxine Versus Fluoxetine. Carol Paton

708 Lamotrigine as Prophylaxis Against Steroid-Induced Mania. Adrian Preda, Amin Fazeli, Bernice G. McKay, Malcolm B. Bowers, Jr., and Carolyn M. Mazure

709 Reserpine Treatment of Comorbid Tourette's Disorder and Tardive Dystonia. Veronica Maria Rojas and Robert K. Davies

710 Adding Other Antipsychotics to Clozapine. Circe Cooke and Jose de Leon

Book Reviews 711

Information for Authors

see July 1999, pages 502-503 or our Web site at